儿童过敏性鼻炎诊疗—临床实践威廉亚洲博彩公司

2019-03-20 中国医师协会儿科医师分会儿童耳鼻咽喉专业委员会 中国实用儿科杂志.2019,34(3):169-175.

儿童AR患者的过敏症状对生活质量有很大的影响。由于儿童AR患者症状易与普通感冒混淆,从而造成很多患儿发病后没有得到及时、正确的诊断和治疗。如何规范性诊治儿童AR,以及减轻该病对儿童生活质量的影响就显得尤为重要。近年来,国内外相继发表了AR相关的临床威廉亚洲博彩公司 ,但专门针对儿童的临床威廉亚洲博彩公司 较少,在临床实践中对儿童特别是婴幼儿AR的诊断和治疗仍存在不规范的问题。因此,中国医师协会儿科医师分会儿童耳鼻咽喉专业委员

中文标题:

儿童过敏性鼻炎诊疗—临床实践威廉亚洲博彩公司

发布日期:

2019-03-20

简要介绍:

儿童AR患者的过敏症状对生活质量有很大的影响。由于儿童AR患者症状易与普通感冒混淆,从而造成很多患儿发病后没有得到及时、正确的诊断和治疗。如何规范性诊治儿童AR,以及减轻该病对儿童生活质量的影响就显得尤为重要。近年来,国内外相继发表了AR相关的临床威廉亚洲博彩公司 ,但专门针对儿童的临床威廉亚洲博彩公司 较少,在临床实践中对儿童特别是婴幼儿AR的诊断和治疗仍存在不规范的问题。因此,中国医师协会儿科医师分会儿童耳鼻咽喉专业委员会基于国内外AR诊疗相关威廉亚洲博彩公司 、临床研究的新进展,并结合儿童耳鼻咽喉科和儿童呼吸科资深专家的临床诊治经验,撰写了适合国情的《儿童过敏性鼻炎诊疗——临床实践威廉亚洲博彩公司 》。该威廉亚洲博彩公司 阐述了儿童AR如何进行规范化诊疗,并希望能向儿科、耳鼻咽喉科,特别是基层医师提供相应的指导性建议。 

拓展威廉亚洲博彩公司 :过敏性鼻炎相关威廉亚洲博彩公司 :

相关资料下载:
[AttachmentFileName(sort=100, fileName=儿童过敏性鼻炎诊疗—临床实践威廉亚洲博彩公司 )] GetToolGuiderByIdResponse(projectId=1, id=296501c001e280e4, title=儿童过敏性鼻炎诊疗—临床实践威廉亚洲博彩公司 , enTitle=, guiderFrom=中国实用儿科杂志.2019,34(3):169-175., authorId=null, author=, summary=儿童AR患者的过敏症状对生活质量有很大的影响。由于儿童AR患者症状易与普通感冒混淆,从而造成很多患儿发病后没有得到及时、正确的诊断和治疗。如何规范性诊治儿童AR,以及减轻该病对儿童生活质量的影响就显得尤为重要。近年来,国内外相继发表了AR相关的临床威廉亚洲博彩公司 ,但专门针对儿童的临床威廉亚洲博彩公司 较少,在临床实践中对儿童特别是婴幼儿AR的诊断和治疗仍存在不规范的问题。因此,中国医师协会儿科医师分会儿童耳鼻咽喉专业委员, cover=, journalId=null, articlesId=null, associationId=1187, associationName=中国医师协会儿科医师分会儿童耳鼻咽喉专业委员会, associationIntro=中国医师协会儿科医师分会儿童耳鼻咽喉专业委员会, copyright=0, guiderPublishedTime=Wed Mar 20 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>儿童AR患者的过敏症状对生活质量有很大的影响。由于儿童AR患者症状易与普通感冒混淆,从而造成很多患儿发病后没有得到及时、正确的诊断和治疗。如何规范性诊治儿童AR,以及减轻该病对儿童生活质量的影响就显得尤为重要。近年来,国内外相继发表了AR相关的临床威廉亚洲博彩公司 ,但专门针对儿童的临床威廉亚洲博彩公司 较少,在临床实践中对儿童特别是婴幼儿AR的诊断和治疗仍存在不规范的问题。因此,中国医师协会儿科医师分会儿童耳鼻咽喉专业委员会基于国内外AR诊疗相关威廉亚洲博彩公司 、临床研究的新进展,并结合儿童耳鼻咽喉科和儿童呼吸科资深专家的临床诊治经验,撰写了适合国情的《儿童过敏性鼻炎诊疗——临床实践威廉亚洲博彩公司 》。该威廉亚洲博彩公司 阐述了儿童AR如何进行规范化诊疗,并希望能向儿科、耳鼻咽喉科,特别是基层医师提供相应的指导性建议。 </div> <div><br> </div>拓展威廉亚洲博彩公司 :<strong>与<font color=red>过敏性鼻炎</font>相关威廉亚洲博彩公司 :</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=76d991c0016102e4" title="中国过敏性鼻炎诊治威廉亚洲博彩公司 (英文版)" target=_blank>中国过敏性鼻炎诊治威廉亚洲博彩公司 (英文版)</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=21c3a1c00152257d" title="2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 :季节性过敏性鼻炎的治疗(更新版)" target=_blank>2017 AAAAI/ACAAI/JCAAI循证威廉亚洲博彩公司 :季节性过敏性鼻炎的治疗(更新版)</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=8cbc61c001a29ec6" title="2017 EAACI意见书:非过敏性鼻炎" target=_blank>2017 EAACI意见书:非过敏性鼻炎</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=ab8491c00136ead0" title="2017 JSA威廉亚洲博彩公司 :过敏性鼻炎" target=_blank>2017 JSA威廉亚洲博彩公司 :过敏性鼻炎</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=a3b3b1c0011e9823" title="过敏性鼻炎皮下免疫治疗专家共识2015" target=_blank>过敏性鼻炎皮下免疫治疗专家共识2015</a></li> 更多信息请点击:<a href="//www.nyrain.com/guideline/list.do?q=%E8%BF%87%E6%95%8F%E6%80%A7%E9%BC%BB%E7%82%8E" target=_blank>有关过敏性鼻炎更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=88282, tagName=儿童过敏性鼻炎)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10287, appHits=1077, showAppHits=23, pcHits=5205, showPcHits=5214, likes=97, shares=90, comments=22, approvalStatus=1, publishedTime=Tue Apr 23 23:39:20 CST 2019, publishedTimeString=2019-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 23 23:39:20 CST 2019, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 21:16:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=儿童过敏性鼻炎诊疗—临床实践威廉亚洲博彩公司 )])
儿童过敏性鼻炎诊疗—临床实践威廉亚洲博彩公司
下载请点击:
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2161326, encodeId=e4a22161326b9, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=436e8859610, createdName=ms5000001725858949, createdTime=Sat Oct 07 12:39:18 CST 2023, time=2023-10-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1182606, encodeId=de581182606e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29666444156, createdName=ms8000001953743897, createdTime=Sun Jan 09 19:53:43 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076661, encodeId=2d5810e6661e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Fri Dec 03 22:21:55 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008453, encodeId=f2fb1008453e6, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:25:56 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008452, encodeId=b41f1008452c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:24:38 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2023-10-07 ms5000001725858949 来自广西

    学习中

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2161326, encodeId=e4a22161326b9, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=436e8859610, createdName=ms5000001725858949, createdTime=Sat Oct 07 12:39:18 CST 2023, time=2023-10-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1182606, encodeId=de581182606e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29666444156, createdName=ms8000001953743897, createdTime=Sun Jan 09 19:53:43 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076661, encodeId=2d5810e6661e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Fri Dec 03 22:21:55 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008453, encodeId=f2fb1008453e6, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:25:56 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008452, encodeId=b41f1008452c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:24:38 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2022-01-09 ms8000001953743897

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2161326, encodeId=e4a22161326b9, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=436e8859610, createdName=ms5000001725858949, createdTime=Sat Oct 07 12:39:18 CST 2023, time=2023-10-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1182606, encodeId=de581182606e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29666444156, createdName=ms8000001953743897, createdTime=Sun Jan 09 19:53:43 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076661, encodeId=2d5810e6661e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Fri Dec 03 22:21:55 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008453, encodeId=f2fb1008453e6, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:25:56 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008452, encodeId=b41f1008452c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:24:38 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2021-12-03 薛鹏

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2161326, encodeId=e4a22161326b9, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=436e8859610, createdName=ms5000001725858949, createdTime=Sat Oct 07 12:39:18 CST 2023, time=2023-10-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1182606, encodeId=de581182606e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29666444156, createdName=ms8000001953743897, createdTime=Sun Jan 09 19:53:43 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076661, encodeId=2d5810e6661e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Fri Dec 03 22:21:55 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008453, encodeId=f2fb1008453e6, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:25:56 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008452, encodeId=b41f1008452c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:24:38 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2021-08-16 一转眼

    学习好资料!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2161326, encodeId=e4a22161326b9, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=436e8859610, createdName=ms5000001725858949, createdTime=Sat Oct 07 12:39:18 CST 2023, time=2023-10-07, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1182606, encodeId=de581182606e5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29666444156, createdName=ms8000001953743897, createdTime=Sun Jan 09 19:53:43 CST 2022, time=2022-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076661, encodeId=2d5810e6661e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201024/67558ad1510145499d4ffbb4720a49f0/db11b160e7384fb99f31c2853d79dc4c.jpg, createdBy=74815279084, createdName=薛鹏, createdTime=Fri Dec 03 22:21:55 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008453, encodeId=f2fb1008453e6, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:25:56 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008452, encodeId=b41f1008452c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a5b5574835, createdName=一转眼, createdTime=Mon Aug 16 21:24:38 CST 2021, time=2021-08-16, status=1, ipAttribution=)]
    2021-08-16 一转眼

    学习了

    0